Virtu KCG Holdings’s Novartis NVS Stock Holding History

Virtu KCG Holdings’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.78M	Buy	63,895 +51,638	+421%	+$3.66M	0.13%	67
2017 Q1	$816K	Sell	12,257 -417	-3%	-$27.8K	0.02%	882
2016 Q4	$827K	Buy	12,674 +4,146	+49%	+$269K	0.02%	937
2016 Q3	$603K	Sell	8,528 -86,440	-91%	-$6.3M	0.01%	1192
2016 Q2	$7.02M	Buy	94,968 +20,197	+27%	+$1.4M	0.15%	44
2016 Q1	$4.85M	Sell	74,771 -61,904	-45%	-$4.21M	0.14%	66
2015 Q4	$10.5M	Sell	136,675 -227,095	-62%	-$18M	0.18%	57
2015 Q3	$30M	Buy	363,770 +323,192	+796%	+$28.8M	0.49%	23
2015 Q2	$3.58M	Buy	40,578 +23,235	+134%	+$2.13M	0.06%	222
2015 Q1	$1.53M	Sell	17,343 -363,692	-95%	-$32.3M	0.03%	502
2014 Q4	$31.6M	Buy	381,035 +369,253	+3,134%	+$30.6M	0.52%	16
2014 Q3	$994K	Sell	11,782 -2,491	-17%	-$202K	0.02%	973
2014 Q2	$1.16M	Sell	14,273 -670,507	-98%	-$52.7M	0.02%	1038
2014 Q1	$52.2M	Buy	684,780 +668,611	+4,135%	+$48.7M	0.65%	21
2013 Q4	$1.16M	Sell	16,169 -608,005	-97%	-$42.3M	0.01%	1081
2013 Q3	$42.9M	Buy	+624,174	New	+$41.3M	0.55%	21

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's NVS Position: Q2 2017 in Review

Virtu KCG Holdings increased its Novartis (NVS) stake by 421% in Q2 2017, buying an estimated $3.66M and bringing the position to 63,895 shares worth $4.78M. The position accounts for 0.13% of the portfolio, ranked #67.

Virtu KCG Holdings first reported a position in NVS in Q3 2013 and has held it in 16 quarters since. The position peaked at $52.2M in Q1 2014. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Virtu KCG Holdings held 63,895 shares of Novartis worth $4.78M as of Q2 2017.
Virtu KCG Holdings bought 51,638 Novartis shares in Q2 2017, an estimated $3.66M.
Novartis made up 0.13% of Virtu KCG Holdings's portfolio in Q2 2017, its #67 holding.
Virtu KCG Holdings first reported a position in Novartis in Q3 2013 and has held it in 16 quarters since.
Virtu KCG Holdings's Novartis position peaked at $52.2M in Q1 2014.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.